From Drug Topics: Continuing education articles for pharmacists and pharmacy technicians - Drug Topics

ADVERTISEMENT

ADVERTISEMENT

Continuing Education
Continuing education for pharmacists and pharmacy technicians

To go directly to the CE site, click here.

For questions pertaining to CEs, e-mail support@classroom24-7.com or call 877-252-7711.

Giving and receiving constructive feedback in pharmacy practice (CE)

June 1, 2009

After participating in this activity, pharmacists and pharmacy technicians should be able to provide timely and constructive feedback to employees, coworkers, and patients, and be able to overcome barriers to providing feedback.

At-home drug testing (CE)

May 1, 2009

In order to counsel patients sensitively and appropriately, every pharmacist and pharmacy technician should be knowledgeable about how and when to use at-home drug tests.

Pain management (CE)

April 1, 2009

Upon completion of this activity, pharmacists should be able to educate other healthcare providers and patients about the nature of pain and the importance of its adequate treatment; recommend appropriate drug therapies for different types of pain; and counsel patients and providers on the difference between addiction, physical dependence, tolerance, and pseudoaddiction.

Biologic agents for the management of rheumatoid arthritis (CE)

March 1, 2009

After participating in this activity, pharmacists should be able to describe the epidemiology and pathophysiology of rheumatoid arthritis (RA); identify its clinical presentation and diagnostic criteria; explain current pharmacologic treatment strategies; discuss the role of the newer, biologic agents; and provide appropriate recommendations for a designated patient.

New drugs update: 2008 approvals (CE)

February 1, 2009

A survey of some of the new molecular entities and biologics approved by FDA in 2008.

Community-acquired MRSA infections (CE)

January 1, 2009

After participating in this activity, pharmacists should be able to distinguish between CA-MRSA and HA-MRSA, recommend outpatient and inpatient treatment options, and identify prevention methods.

The pharmacist's duty to warn: Implications for pharmacy practice (CE)

December 15, 2008

Case law concerning a pharmacist's duty to warn varies from state to state. Certain guidelines should be observed by all pharmacists, regardless of where they practice.

Weighing the complications of obesity (CE)

November 10, 2008

The complications of obesity affect nearly every organ system. Treatment approaches include pharmacotherapy, modification of behavior and lifestyle, and surgery. Analysis of the root cause for each patient is essential.

Sitagliptin–a newer treatment option for type 2 diabetes mellitus (CE)

October 13, 2008

Sitagliptin is an incretin mimetic that targets mainly postprandial glucose in the treatment of patients with type 2 diabetes mellitus. It provides a modest reduction in HbA1c and may be an option for certain patients who are not achieving established glycemic controls.

Drug Topics Issue
Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION

ADVERTISEMENT

Survey
What do you spend the most time counseling customers on?
OTC medications
Painkillers
Adverse drug reactions
Other
View Results
OTC medications
57%
Painkillers
13%
Adverse drug reactions
21%
Other
9%
View Results

Modern Medicine logoDrug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Click here